Clinical trials
Psoriasis trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
122 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 13 |
| 2011 | 5 |
| 2012 | 10 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 12 |
| 2020 | 10 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 88 |
| Recruiting | 13 |
| Terminated | 11 |
| Active, not recruiting | 5 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 10 |
| Novartis Pharmaceuticals | 10 |
| Assistance Publique - Hôpitaux de Paris | 8 |
| Boehringer Ingelheim | 7 |
| LEO Pharma | 6 |
| Pfizer | 6 |
| Bristol-Myers Squibb | 5 |
| AbbVie | 4 |
| Bausch Health Americas, Inc. | 4 |
| Centre Hospitalier Universitaire de Nice | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psoriasis | 122 |
| Arthritis, Psoriatic | 16 |
| Dermatitis | 8 |
| Plaque, Amyloid | 7 |
| Skin Diseases | 7 |
| Arthritis | 6 |
| Arthritis, Rheumatoid | 6 |
| Dermatitis, Atopic | 6 |
| Pruritus | 6 |
| Crohn Disease | 5 |
Trials
Showing 1 to 25 of 122. Each trial links to its page on Pharma Observatory.
22 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.